Shanghai Haohai Biological Technology Co (688366.SS) Stock Price
Shanghai Haohai Biological Technology Co Price
Shanghai Haohai Biological Technology Co (688366.SS) Stock | ISIN CNE100003NX4. The current Shanghai Haohai Biological Technology Co stock price is 31.6 CNY (2026). Revenue is 2.91 B CNY. Net income is 568.8 M CNY. The P/E ratio is 12.98. Market capitalization is 7.38 B CNY. Shanghai Haohai Biological Technology Co operates in the Health sector.
Shanghai Haohai Biological Technology Co stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Shanghai Haohai Biological Technology Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Shanghai Haohai Biological Technology Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Shanghai Haohai Biological Technology Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Shanghai Haohai Biological Technology Co Price |
|---|
Shanghai Haohai Biological Technology Co Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Shanghai Haohai Biological Technology Co Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M CNY) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M CNY) |
| NET INCOME (M CNY) |
| NET INCOME GROWTH (%) |
| DIVIDEND (CNY)DIV. (CNY) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Shanghai Haohai Biological Technology Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Shanghai Haohai Biological Technology Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Shanghai Haohai Biological Technology Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Shanghai Haohai Biological Technology Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Shanghai Haohai Biological Technology Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Shanghai Haohai Biological Technology Co stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Shanghai Haohai Biological Technology Co Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Shanghai Haohai Biological Technology Co business model & stock analysis
Shanghai Haohai Biological Technology Co SWOT Analysis
Strengths
Shanghai Haohai Biological Technology Co Ltd possesses several strengths that contribute to its competitive advantage in the market. These strengths include:
- Strong Research and Development capabilities
- Advanced technology infrastructure
- Extensive product portfolio
- Strong brand reputation
- Well-established distribution network
Weaknesses
Despite its strengths, Shanghai Haohai Biological Technology Co Ltd also faces certain weaknesses that can hinder its growth and performance. These weaknesses include:
- Limited global market presence
- Dependence on a few key suppliers
- Relative lack of brand awareness in international markets
- Higher production costs compared to some competitors
Opportunities
Shanghai Haohai Biological Technology Co Ltd can leverage various opportunities to expand its market presence and enhance its business prospects. These opportunities include:
- Growing demand for bio-based products
- Expansion into emerging markets
- Collaboration with research institutions and academia
- Product diversification into new sectors
Threats
Shanghai Haohai Biological Technology Co Ltd must also be mindful of potential threats that could impact its business operations and performance. These threats include:
- Intense competition from domestic and international firms
- Changing regulatory environment and compliance requirements
- Fluctuating raw material prices
- Economic uncertainties and market fluctuations
Shanghai Haohai Biological Technology Co Eulerpool Fair Value
Shanghai Haohai Biological Technology Co historical P/E ratio, EBIT multiple, and P/S ratio
Shanghai Haohai Biological Technology Co annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Shanghai Haohai Biological Technology Co shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Shanghai Haohai Biological Technology Co Dividend History
6 years of dividend payments
Shanghai Haohai Biological Technology Co dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Shanghai Haohai Biological Technology Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Shanghai Haohai Biological Technology Co shareholder structure
| % | Name |
|---|---|
28.4817% | |
17.26163% | |
3.63715% | |
3.59993% | |
3.04828% | |
1.6962% | |
1.19872% | |
1.19872% | |
0.32942% | |
0.23637% |
Shanghai Haohai Biological Technology Co Executives and Management Board
Mr. Jianying Wu
(55)General Manager, Executive Director · since 2010
Mr. Yongtai Hou
(63)Executive Chairman of the Board · since 2010
Mr. Minjie Tang
(50)Finance Director, Executive Director · since 2016
Ms. Yiyi Chen
(38)Executive Director · since 2014
Mr. Jundong Zhang
(51)Deputy General Manager
Shanghai Haohai Biological Technology Co Supply Chain
Frequently asked questions about Shanghai Haohai Biological Technology Co
The business model of Shanghai Haohai Biological Technology Co Ltd focuses on the development, production, and sale of pharmaceutical products. As a leading biotechnology company in China, Shanghai Haohai Biological Technology Co Ltd primarily engages in the research and manufacturing of innovative medicines, including both chemical drugs and biological drugs. By leveraging its extensive expertise in the biopharmaceutical industry, the company aims to provide effective and safe healthcare solutions to patients worldwide. With a strong emphasis on technological innovation and quality control, Shanghai Haohai Biological Technology Co Ltd strives to become a trusted provider of advanced pharmaceutical products, contributing to the improvement of global healthcare standards.
Shanghai Haohai Biological Technology Co stock
Shanghai Haohai Biological Technology Co Peer Group
Shanghai Haohai Biological Technology Co Ticker
Shanghai Haohai Biological Technology Co FIGI
All fundamentals and in-depth analysis of Shanghai Haohai Biological Technology Co
Our stock analysis for Shanghai Haohai Biological Technology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Haohai Biological Technology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.